No involvement of alpha 2-adrenoceptors in the regulation of basal prolactin secretion in healthy men

Psychoneuroendocrinology. 1990;15(2):125-9. doi: 10.1016/0306-4530(90)90020-a.

Abstract

The role of alpha 2-adrenoceptors in the regulation of basal prolactin secretion was investigated in healthy male volunteers. Two independent, placebo-controlled, double-blind experiments were performed. In the first experiment, 50 micrograms dexmedetomidine (MPV-1440), a selective alpha 2-adrenoceptor agonist, and saline placebo were infused (IV) in five subjects. In the second experiment, 100 mg atipamezole (MPV-1248), a selective alpha 2-adrenoceptor antagonist, and saline placebo were infused in six volunteers. The concentrations of prolactin in plasma were not affected by the drugs. These results suggest that alpha 2-adrenoceptors do not a play significant role in the control of basal prolactin secretion in healthy men.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology*
  • Adult
  • Analysis of Variance
  • Clinical Trials as Topic
  • Double-Blind Method
  • Humans
  • Imidazoles / pharmacology*
  • Male
  • Medetomidine
  • Prolactin / blood
  • Prolactin / metabolism*
  • Receptors, Adrenergic, alpha / drug effects*
  • Receptors, Adrenergic, alpha / physiology
  • Reference Values

Substances

  • Adrenergic alpha-Agonists
  • Imidazoles
  • Receptors, Adrenergic, alpha
  • atipamezole
  • Prolactin
  • Medetomidine